310 related articles for article (PubMed ID: 16607372)
1. Comprehensive analysis of HE4 expression in normal and malignant human tissues.
Galgano MT; Hampton GM; Frierson HF
Mod Pathol; 2006 Jun; 19(6):847-53. PubMed ID: 16607372
[TBL] [Abstract][Full Text] [Related]
2. Detection of the HE4 protein in urine as a biomarker for ovarian neoplasms.
Hellstrom I; Heagerty PJ; Swisher EM; Liu P; Jaffar J; Agnew K; Hellstrom KE
Cancer Lett; 2010 Oct; 296(1):43-8. PubMed ID: 20381233
[TBL] [Abstract][Full Text] [Related]
3. The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma.
Hellström I; Raycraft J; Hayden-Ledbetter M; Ledbetter JA; Schummer M; McIntosh M; Drescher C; Urban N; Hellström KE
Cancer Res; 2003 Jul; 63(13):3695-700. PubMed ID: 12839961
[TBL] [Abstract][Full Text] [Related]
4. WFDC2 (HE4): a potential role in the innate immunity of the oral cavity and respiratory tract and the development of adenocarcinomas of the lung.
Bingle L; Cross SS; High AS; Wallace WA; Rassl D; Yuan G; Hellstrom I; Campos MA; Bingle CD
Respir Res; 2006 Apr; 7(1):61. PubMed ID: 16600032
[TBL] [Abstract][Full Text] [Related]
5. Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas.
Drapkin R; von Horsten HH; Lin Y; Mok SC; Crum CP; Welch WR; Hecht JL
Cancer Res; 2005 Mar; 65(6):2162-9. PubMed ID: 15781627
[TBL] [Abstract][Full Text] [Related]
6. The putative ovarian tumour marker gene HE4 (WFDC2), is expressed in normal tissues and undergoes complex alternative splicing to yield multiple protein isoforms.
Bingle L; Singleton V; Bingle CD
Oncogene; 2002 Apr; 21(17):2768-73. PubMed ID: 11965550
[TBL] [Abstract][Full Text] [Related]
7. Large-scale molecular and tissue microarray analysis of mesothelin expression in common human carcinomas.
Frierson HF; Moskaluk CA; Powell SM; Zhang H; Cerilli LA; Stoler MH; Cathro H; Hampton GM
Hum Pathol; 2003 Jun; 34(6):605-9. PubMed ID: 12827615
[TBL] [Abstract][Full Text] [Related]
8. Serum HE4 concentration differentiates malignant ovarian tumours from ovarian endometriotic cysts.
Huhtinen K; Suvitie P; Hiissa J; Junnila J; Huvila J; Kujari H; Setälä M; Härkki P; Jalkanen J; Fraser J; Mäkinen J; Auranen A; Poutanen M; Perheentupa A
Br J Cancer; 2009 Apr; 100(8):1315-9. PubMed ID: 19337252
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic and prognostic impact of serum HE4 detection in endometrial carcinoma patients.
Bignotti E; Ragnoli M; Zanotti L; Calza S; Falchetti M; Lonardi S; Bergamelli S; Bandiera E; Tassi RA; Romani C; Todeschini P; Odicino FE; Facchetti F; Pecorelli S; Ravaggi A
Br J Cancer; 2011 Apr; 104(9):1418-25. PubMed ID: 21468050
[TBL] [Abstract][Full Text] [Related]
10. Comparison of serum human epididymis protein 4 with cancer antigen 125 as a tumor marker in patients with malignant and nonmalignant diseases.
Escudero JM; Auge JM; Filella X; Torne A; Pahisa J; Molina R
Clin Chem; 2011 Nov; 57(11):1534-44. PubMed ID: 21933899
[TBL] [Abstract][Full Text] [Related]
11. Ovarian cancer and normal fallopian tube high WFDC2 expression does not correlate with HE4 serum level.
Gąsiorowska E; Walkowiak GP; Warchoł W; Lemańska A; Jankowska A; Nowak-Markwitz E
Ginekol Pol; 2015 May; 86(5):335-9. PubMed ID: 26117969
[TBL] [Abstract][Full Text] [Related]
12. Co-expression of Lewis y antigen with human epididymis protein 4 in ovarian epithelial carcinoma.
Zhuang H; Gao J; Hu Z; Liu J; Liu D; Lin B
PLoS One; 2013; 8(7):e68994. PubMed ID: 23894390
[TBL] [Abstract][Full Text] [Related]
13. Human epididymis protein 4 is a biomarker for transitional cell carcinoma in the urinary system.
Xi Z; LinLin M; Ye T
J Clin Lab Anal; 2009; 23(6):357-61. PubMed ID: 19927341
[TBL] [Abstract][Full Text] [Related]
14. HE4 and mesothelin: novel biomarkers of ovarian carcinoma in patients with pelvic masses.
Abdel-Azeez HA; Labib HA; Sharaf SM; Refai AN
Asian Pac J Cancer Prev; 2010; 11(1):111-6. PubMed ID: 20593939
[TBL] [Abstract][Full Text] [Related]
15. HE4 as a biomarker for ovarian and endometrial cancer management.
Li J; Dowdy S; Tipton T; Podratz K; Lu WG; Xie X; Jiang SW
Expert Rev Mol Diagn; 2009 Sep; 9(6):555-66. PubMed ID: 19732003
[TBL] [Abstract][Full Text] [Related]
16. Human epididymis protein 4 (HE4) as a serum tumor biomarker in patients with ovarian carcinoma.
Chang X; Ye X; Dong L; Cheng H; Cheng Y; Zhu L; Liao Q; Zhao Y; Tian L; Fu T; Chen J; Cui H
Int J Gynecol Cancer; 2011 Jul; 21(5):852-8. PubMed ID: 21633297
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of HE4 expression in pulmonary adenocarcinoma.
Yamashita S; Tokuishi K; Hashimoto T; Moroga T; Kamei M; Ono K; Miyawaki M; Takeno S; Chujo M; Yamamoto S; Kawahara K
Tumour Biol; 2011 Apr; 32(2):265-71. PubMed ID: 20953751
[TBL] [Abstract][Full Text] [Related]
18. HE4 transcription- and splice variants-specific expression in endometrial cancer and correlation with patient survival.
Jiang SW; Chen H; Dowdy S; Fu A; Attewell J; Kalogera E; Drapkin R; Podratz K; Broaddus R; Li J
Int J Mol Sci; 2013 Nov; 14(11):22655-77. PubMed ID: 24252907
[TBL] [Abstract][Full Text] [Related]
19. Expression of a new mucin-type glycoprotein in select epithelial dysplasias and neoplasms detected immunocytochemically with Mab A-80.
Shin SS; Gould VE; Gould JE; Warren WH; Gould KA; Yaremko ML; Manderino GL; Rittenhouse HG; Tomita JT; Jansson DS
APMIS; 1989 Dec; 97(12):1053-67. PubMed ID: 2611021
[TBL] [Abstract][Full Text] [Related]
20. HE4: a new potential early biomarker for the recurrence of ovarian cancer.
Anastasi E; Marchei GG; Viggiani V; Gennarini G; Frati L; Reale MG
Tumour Biol; 2010 Apr; 31(2):113-9. PubMed ID: 20358424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
